MORE►
Bayer AG
Illustration: paitoonpati/iStock
Follow the Money: Jacobs Lands Nearly $4B NASA Contract; Dallas’ ReCode Therapeutics Adds $120M to Series B Raise, and More
by Kevin Cummings | Jul 11, 2022
Plus, Enhabit Home Health Hits the NYSE, Irving Web3 Investor Raising Two New Funds, TPG leads $750M raise in clean energy firm; Coppell-based Neurolens raises $2.7M; Fort Worth's Jet Health raises $1M; Frisco edtech startup Meritize lands funding; Honeywell acquires Fort Worth nitrile glove maker Rhino Health USA; and more North Texas-related deals.
by Kevin Cummings |
Jun 29, 2022
ReCode Therapeutics, a biopharmaceutical startup using a non-viral lipid nanoparticle delivery platform for gene therapies, has closed a $120 million extension to a funding round it raised last year to help bring its lead programs to human trials and “follow the science” to target new diseases.
With a research team working out of BioLabs' life sciences facility at Pegasus Park, ReCode aims to grow its global team from about 70 to 100 over the next year.
MORE►
